RETINOID REGISTER · KNOW YOUR ACTIVERESEARCHED OCTOBER 2026
retinoidregister ↗
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
COMPOUNDED TRETINOIN

CoreAge Rx Smooth Move review

The tretinoin-containing blend, with ingredient strengths and follow-up to confirm during prescribing.

Named ingredients
Tretinoin, niacinamide, vitamin C
Starting price
$42/month
Exact strengths
Not established by the public page

Begin with the actual prescription

Smooth Move’s public page identifies three ingredients but does not provide verified concentrations for this review. The product is presented for fine lines, texture and tone through an online clinical assessment.[source]

Ask what tretinoin strength is proposed and which vitamin C form is used. A familiar ingredient combination can differ in stability, base and instructions, so it should not be equated automatically with another service’s cream.

The retinoid is part of a complete formula

Niacinamide and vitamin C contribute to the formulation’s positioning, but adding supporting ingredients does not by itself prove that the preparation is more effective or less irritating than a comparator. We did not identify a controlled trial establishing that advantage.

FDA approval of a specific tretinoin medicine does not transfer to this compounded blend. The relevant distinction is the finished product’s status, not whether an ingredient has previously appeared in an approved drug.[source]

Price and follow-up should be equally specific

The $42 monthly starting figure needs a selected supply period and actual invoice. Confirm the quantity, renewal and consultation terms in the chosen plan.[source]

Also establish how response and irritation will be reviewed. A prescription should come with instructions appropriate to the person, including consideration of other actives and pregnancy-related precautions. This review is a preparation for that conversation, not a suggested concentration or application schedule. Commercial first placement does not establish superior safety or results.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.

  1. CoreAge Rx: Smooth MoveOfficial source; checked October 8, 2026
  2. FDA: compounded preparationsOfficial source; checked October 8, 2026
  3. CoreAge Rx: treatment catalog and plan termsOfficial source; checked October 8, 2026

Keep reading